Navigation Links
Out-of-Pocket Costs Limit Access to Arthritis Drugs

Insurance woes keep rheumatoid arthritis patients from biologic meds, study finds

TUESDAY, May 25 (HealthDay News) -- Effective but expensive biologic drugs are less likely to be used by American rheumatoid arthritis patients who have inadequate health insurance or are struggling with medical co-payments, a new study reveals.

Biologics, which alter immune system function, are sometimes used to treat rheumatoid arthritis when more conventional treatments don't work.

"Our study showed that out-of-pocket cost is a concern in the decision to initiate these drugs," lead author Pinar Karaca-Mandic, an assistant professor in the School of Public Health at the University of Minnesota, said in a news release. "If higher cost-sharing forces people away from preferred, effective therapy, they could end up with higher complication and medical costs."

Karaca-Mandic and her research team released their findings online May 24 in advance of publication in an upcoming print issue of the journal Health Services Research.

The cautionary note stems from an analysis of health insurance data gleaned from 35 large, private U.S. employers from 2000 to 2005.

From a pool of more than 8,500 newly diagnosed rheumatoid arthritis patients, the authors found that 2,066 of them had used one of the three most commonly prescribed biotech drugs: etanercept (Enbrel), adalimumab (Humira) or infliximab (Remicade).

However, the team found that the likelihood of taking any of these drugs was lower among patients who had to pay more for them. What's more, unmanageable costs also raised the risk that those who started a biotech regimen would end up abandoning the treatment.

Rheumatoid arthritis patients from families already burdened with high health costs overall were less than 50 percent as likely to begin a biotech regimen in the first place, the authors found, although those who did so anyway were not more likely to stop once they started.

"Families have a separate budget for health care, and may not be flexible around expanding it," noted Karaca-Mandic. "If other members are getting sick, they may want to draw resources away from the rheumatoid arthritis patient."

More information

For more on rheumatoid arthritis, visit the U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases.

-- Alan Mozes

SOURCE: Health Behavior News Service, news release, May 21, 2010

Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. National Patient Advocate Foundation Delivers Constituent Cases to White House Health Summit Participants to Urge Elimination of Pre-Existing Conditions, Annual/Lifetime Limits and Capping Out-of-Pocket Expenses
2. Corporate health program reduces employee CVD medical, hospital costs
3. Insightful Case Study Details How Electronic Payment Exchange Saved a Global Firm More Than $3 Million in PCI-Related Costs
4. Medical Devices Driving Up Heart Care Costs
5. New Healthcare Book Helps Families Navigate Rising Healthcare Costs and Decreasing Coverage
6. Alzheimers Costs Could Explode by Mid-Century
7. Study shows costs and benefits of testosterone in birds
8. U.S. Cancer Costs Double in Two Decades
9. Medical costs of cancer have nearly doubled over the past 2 decades
10. PCMA: New Legislation Would Increase Prescription Drug Costs, Limit Access
11. Urgent Nuclear Stress Test Lab Costs Reductions for Physician Practices in Need
Post Your Comments:
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... An inventor ... life in the womb. "My last baby had high blood pressure due to loud ... mothers to protect their babies from noise pollution as well as radio waves and ...
(Date:11/30/2015)... York (PRWEB) , ... November 30, 2015 , ... In ... of his role as a top ophthalmologist on Long Island’s east end. During the ... teaching, innovations in surgery and treatment of glaucoma and cataracts, and how a visit ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... and websites specializing in independent living, assisted living and all other retirement options. ... Alzheimer’s awareness and research remains a top priority. , So it’s ...
(Date:11/30/2015)... ... 30, 2015 , ... Holcomb – Kreithen Plastic Surgery ... practices in Florida, is proud to announce that Dr. Joshua Kreithen, one of ... Inc., a Johnson & Johnson Company. , Ethicon is a global medical device ...
(Date:11/30/2015)... , ... November 30, 2015 , ... Sikka Software announced ... Dental Meeting. Their Ecosystem empowers dentists to make complex business decisions by providing the ... will receive a free fee survey with 10 procedures customized by zip code. ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... LONDON and BOSTON , ... to research and develop potential new medicines directed at ... multiple therapeutic areas. --> PFE ) to ... to 10 G protein-coupled receptor (GPCR) targets across multiple ... clinical-stage GPCR structure-guided drug discovery and development company and ...
(Date:11/30/2015)... and REHOVOT, Israel , Nov. ... pharmaceutical company focused on acquiring and developing innovative therapies ... the appointment of Keith A. Katkin as ... Gregory J. Flesher , chief executive officer for OticPharma, ... successful organizations.  As chairman, he will be able to ...
(Date:11/30/2015)... 2015 Sectra (STO: SECT ... entered into a multi-year agreement to provide Breast Imaging ... Kentucky Breast Care to increase collaboration with sub-specialists around ... patients. --> Sectra (STO: SECT ... entered into a multi-year agreement to provide Breast Imaging ...
Breaking Medicine Technology: